Sequential grafting may be an effective way to maximize the benefits of the left internal mammary artery (LIMA) conduit. Despite increasing clinical application, the strategy of sequential LIMA grafting has not been proven its superiority. This single-center retrospective study aimed to evaluate the in-hospital and mid-term outcomes of sequential grafting of in situ skeletonized LIMA to the left coronary system.
T he left internal mammary artery (LIMA) conduit compared with other arterial and venous conduits has been demonstrated to a superior graft patency and has provided excellent long-term clinical results. 1) For decades, in situ LIMA grafting to the left anterior descending artery (LAD) is considered as the "gold standard" of coronary revascularization. 2, 3) To maximize the benefits of the LIMA conduit, previous studies reported a sequential anastomotic technique that uses LIMA for grafting more than one major epicardial coronary artery at one time. [4] [5] [6] [7] The skeletonized harvesting method of internal mammary artery achieves maximal length and facilitates the ease of sequential grafting. 8) So far, the uptake of sequential LIMA grafting among cardiac surgeons has been variable. The criticism of sequential LIMA grafting centered on the dependance of multiple grafts on a common inflow with the possibility of catastrophic consequences in the event of a proximal occlusion. Some surgeons opposing this technique have cited the disadvantages of increased conduit manipulation and the complexity of certain side-to-side anastomoses. 9) However, the advocates of the sequential anastomotic technique described the hemodynamic advantage of increased total graft flow through improved distal runoff and, by extension, increased graft patency rate. Despite increasing clinical application, the strategy of sequential LIMA grafting has not been proven the superiority. Furthermore, data on the basis of either clinical outcomes or LIMA graft patency of sequential LIMA grafting were scant.
Additionally, there were two sequential LIMA graft configurations: one is sequential grafting of in situ skeletonized LIMA to the diagonal artery (D) and then to the LAD (LIMA-D-LAD), and the other is sequential grafting of the in situ skeletonized LIMA to the D and then to the obtuse marginal artery (OM) (LIMA-D-OM). The former Ji, ET AL was a common practice in many medical centers, 4, 5, 7) whereas the latter rarely reported so far.
In the current study, 1505 eligible patients in our medical center were reviewed and followed up to provide a present-day assessment of the impacts of sequential LIMA grafting versus separate LIMA grafting on the clinical outcomes and LIMA graft patency. Additionally, this study also sought to evaluate the clinical outcomes and LIMA graft patency between the two sequential LIMA graft configurations.
Methods
Study population: After approval by the ethics committee of Zhongshan Hospital Fudan University, in accordance with the Declaration of Helsinki, the records of well-documented patients who received first, scheduled, isolated CABG procedure with in situ skeletonized LIMA grafting to the left coronary system at our medical center from July 2012 to June 2015 were investigated. Patients who received separate grafting of LIMA to the D or OM were excluded to minimize surgical variability. Octogenarians and patients with concomitant malignant tumor were excluded due to limited anticipated life expectancy. And patients with concomitant serious chronic obstructive pulmonary disease and/or a history of chest radiotherapy may not be suitable candidates for sequential or separate LIMA grafting, and then were also excluded. In addition, patients with hyperthyroidism, iodine contrast medium allergy, atrial fibrillation, and renal insufficiency may not be suitable candidates for noninvasive coronary computed tomographic (CT) angiographic examination, and thus were not involved in the final analysis. Study protocols: According to the use of sequential or separate LIMA grafting, all included patients were assigned to two groups: a sequential group and a control group. Furthermore, according to sequential LIMA graft configurations, patients with sequential LIMA grafting were assigned to two subgroups: a DOM subgroup (patients receiving sequential grafting of LIMA to the D and then to the OM with additional conduits grafting) and a DLAD subgroup (patients receiving sequential grafting of LIMA to the D and then to the LAD with additional conduits grafting). The in-hospital adverse events, follow-up adverse events, and follow-up LIMA graft patency rate were investigated and compared.
The in-hospital adverse events included surgical mortality, 10) myocardial infarction associated with CABG, 11) prolonged ventilation (> 48 hours), 11) reoperation prior to discharge from hospital, peri-operative stroke, 11) and deep sternal wound infection.
12) Follow-up adverse events included all-cause mortality and repeat revascularization. All-cause mortality rather than cardiac-cause mortality was chosen because it was the most robust and unbiased index which exempted us from misreading the cause of death with the subjective and sometimes inaccurate medical records. Repeat revascularization was defined as a second percutaneous coronary intervention or redo CABG surgery to deal with graft failure or new high-grade native coronary artery stenosis.
Follow-up LIMA graft patency rate was determined by noninvasive coronary CT angiography with a 64-slice, dual-source CT (iCT 64, Philips Healthcare, Amsterdam, Netherlands). The images were analyzed in off-line work stations (median effective irradiation of 7.5 mSv, interquartile range 3.76 mSv). In the case of sequential LIMA grafting, sequential LIMA graft was divided into two graft segments. All LIMA grafts or segments were evaluated for patency and assigned a FitzGibbon grade of A (< 50% lumen diameter reduction, and/or reducing caliber of anastomosis to < 50% of the grafted coronary artery), B (!50% lumen diameter reduction, and/or reducing caliber of anastomosis to ! 50% of the grafted coronary artery), or O (complete occlusion). 13) In the case of sequential LIMA grafting, graft patency of the first LIMA-target coronaries sites included FitzGibbon grade of A patency of LIMA segments prior to the first anastomoses and of the first anastomoses, and graft patency of the second sites included FitzGibbon grade of A patency of LIMA segments between the two anastomoses and of the second anastomoses.
Surgical techniques:
The aim of surgery is to achieve complete revascularization, which is defined as grafting to all epicardial coronary arteries !1.5 mm with a diameter reduction !50% in at least one angiographic view. 14) Detailed CABG technique has been described in previous literatures. 12, 15) The skeletonized technique of internal mammary artery was also described in a previous report.
12) All anastomoses of LIMA-target native coronaries were conducted with a double-armed 8-0 polypropylene suture and a continuous suturing technique. When planning sequential LIMA grafting, the size of the former anastomosis (a parallel-shaped anastomosis, "side-to-side fashion") was smaller than that of the latter anastomosis ("end-to-side fashion").
The quality of anastomosis was assessed after grafting with a transit-time flow probe (Medistim Butterfly Flowmeter, Oslo, Norway) during the operation. Systolic blood pressure was maintained around 110-120 mmHg and a heart rate around 80 beats per minute. The probe size was selected to fit the graft tightly without compressing it. The value of graft flow associated with measured pulsatility index (PI) was obtained under the conditions of apnea for around 10 seconds. When the probe applied to the sequential LIMA segments prior to the first anastomosis without clamping sequential LIMA segments between the two anastomoses, the obtained value was considered as the value of "trunk flow" of sequential LIMA grafts. Statistical analysis: Preoperative data were obtained from our institutional database and were reviewed using a standard data collection form. Follow-up data were obtained by telephone, letter, and clinic visit. Data collection was performed by trained staff (two people). The trained staff, however, did not know the purpose of the current study.
Categorical variables were represented as frequency distributions and single percentages. Values of continuous variables were expressed as a mean ± standard deviation. Normally distributed continuous variables were compared using a Student's t-test, non-normally distributed continuous variables using the Mann-Whitney U test, and categorical variables were compared by χ 2 test or Fisher's exact test. The impacts of grouping (sequential LIMA graft-SEQUENTIAL LIMA GRAFTING ing versus separate LIMA grafting) as an independent risk factor on in-hospital adverse events were further analyzed by using multivariable logistic regression analysis. Followup survival free from repeat revascularization was analyzed by the Kaplan-Meier method with the log-rank test for group comparisons. Cox regression analysis was used to assess the impact of grouping (sequential LIMA grafting versus separate LIMA grafting) as an independent risk factor on follow-up survival free from repeat revascularization. All statistical tests were two-sided. Results were considered statistically significant at a level of P less than 0.05. All analyzes were performed with the SPSS statistical package version 17.0 (SPSS Inc, Chicago, IL, USA).
Results
Study population: A total of 2682 consecutive patients received CABG surgery at our medical center from July 2012 to June 2015. As presented in Figure 1 , 1505 eligible patients were finally analyzed. Among them, 230 patients who received sequential grafting of in situ skeletonized LIMA to the left coronary system with additional conduits grafting were entered into the sequential group, and the remaining 1275 patients who received separate grafting of in situ skeletonized LIMA to the LAD with additional conduits grafting were entered into the control group. As shown in Table I , no significant differences were found between the sequential group and the control group in baseline characteristics except age and the proportion of older age. Patients in the sequential group were younger than those in the control group.
The number of bypass conduits in this cohort ranged from 2 to 6 (3.4 ± 0.6). Table II lists the grafts and target coronary arteries. It was noteworthy that all patients in the sequential group, whereas 82.4% of patients in the control group, received the revascularization of the diagonal artery. Patients in the sequential group compared with the control group received a larger number of bypass conduits (3.5 ± 0.7 versus 3.4 ± 0.6, P = 0.023) and higher proportions of use of right internal mammary artery and radial artery (50.9% versus 2.4%, P < 0.001; 41.7% versus 7.8%, P < 0.001, respectively). Graft flow of all LIMA grafts and segments were higher than 15 mL/minute associated with measured PI below 5. The trunk flow of LIMA graft in the sequential group was significantly higher than graft flow of LIMA-LAD graft in the control group (46 ± 11 mL/minute versus 37 ± 10 mL/minute, P < 0.001), whereas LIMA graft flow between two sequential anastomoses in the sequential group was significantly lower than that of LIMA-LAD graft in the control group (31 ± 8 mL/minute versus 37 ± 10 mL/minute, P < 0.001). In-hospital adverse events: As presented in Table III , no significant differences were found between the two groups in the in-hospital adverse events, including surgical mortality and major postoperative morbidity (all P > 0.05).
The impacts of grouping (the sequential group versus the control group) on in-hospital adverse events after adjustment for potential confounders (age, gender, smoking history, diabetes, hypertension, hyperlipidemia, history of cerebrovascular disease, recent myocardial infarction, impaired left ventricular function, enlarged left ventricle, coronary artery lesion, and the number of grafts) are shown in Table IV . In multivariable logistic regression analysis, sequential LIMA grafting was not found to be an independent predictor of in-hospital adverse events. Follow-up adverse events: A total of 1399 patients (222 in the sequential group and 1177 in the control group) were followed up for 12 to 56 months (32.4 ± 8.5 months). Fifty-nine patients died, and follow-up all-cause mortality was 4.2%. A total of 39 patients received repeat revascularization during follow-up. Patients in the sequential group compared with the control group had a trend toward a lower ratio of repeat revascularization (1.8% versus 3.0%, P = 0.331). Only 1 patient (in the control group) underwent repeat on-pump CABG surgery due to LIMA graft occlusion, and the remaining 38 patients preferred to percutaneous coronary intervention. In the sequential group, intervention was performed on 1 sequential LIMA graft (between the D and the OM), 1 radial artery graft (grafting to the posterior descending branch artery), and 2 saphenous vein grafts (grafting to the posterior descending branch artery in 1 and grafting to the OM in 1). In the control group, intervention was performed on 2 LIMA grafts (grafting to the LAD), 4 radial artery grafts (grafting to the posterior descending branch artery in 3, and grafting to the D in 1), 22 saphenous vein grafts (grafting to the posterior descending branch artery in 8, grafting to the OM in 8, and grafting to the D in 6), 4 native coronary arteries distal to the insertion of grafts, and 2 native coronary arteries without grafting. As presented in Figure 2 , the Kaplan-Meier curves showed the sequential group compared with the control group was associated with a similar follow-up survival free from repeat revascularization (χ 2 = 2.794, log-rank P = 0.095). Cox regression analysis revealed that grouping (sequential LIMA grafting versus separate LIMA grafting) was not a significant variable related to follow-up survival free from repeat revascularization (HR = 1.324, 95% CI: 0.813-2.886, P = 0.121). Follow-up LIMA graft patency rate: A total of 1371 patients (221 in the sequential group and 1150 in the control group) received noninvasive coronary CT angiographic examination at 12 to 54 months (32.3 ± 8.5 months) after CABG surgery. FitzGibbon grade of A patency was observed in 99.5% of the first LIMA-target coronaries sites and 97.7% of the second sites after sequential LIMA grafting, and in 98.2% of LIMA-LAD grafts after separate LIMA grafting. FitzGibbon grade of O patency was observed in only 1 LIMA-LAD grafts in the control group. No significant difference was found in follow-up LIMA graft patency rate between the two groups. Subgroup analysis: As shown in Table V , no significant differences were found between the two subgroups in the baseline characteristics except age and the proportion of older age. And there were not significant differences between the two subgroups in surgical characteristics except the proportion of use of right internal mammary artery. Additionally, the two subgroups received similar incidences of in-hospital adverse events.
A total of 222 patients were followed up for 12 to 56
Ji, ET AL Figure 1 . Study population. CABG indicates coronary artery bypass grafting; LIMA, left internal mammary artery; DOM subgroup, patients receiving sequential grafting of in situ skeletonized LIMA to the diagonal artery and then to the obtuse marginal artery; and DLAD subgroup, patients undergoing sequential grafting of in situ skeletonized LIMA to the diagonal artery and then to the left anterior descending artery.
months (32.3 ± 8.1 months). Nine patients died, and follow-up all-cause mortality was 4.0%. Four patients (2 in the DOM subgroup and 2 in the DLAD subgroup) received repeat revascularization and preferred to percutaneous coronary intervention during follow-up. In the DOM subgroup, intervention was performed on 1 sequential LIMA segment (between the D and the OM) and 1 saphenous vein graft (grafting to the posterior descending branch artery). In the DLAD subgroup, intervention was performed on 1 radial artery graft (grafting to the posterior descending branch artery) and 1 saphenous vein graft (grafting to the OM). As presented in Figure 3 , the Kaplan-Meier curves showed the two subgroup was associated with a similar follow-up survival free from repeat revascularization (χ 2 = 1.300, log-rank P = 0.254). A total of 221 patients received noninvasive coronary CT angiographic examination at 12 to 54 months (32. O patency was observed in all LIMA segments. In the DOM subgroup, FitzGibbon grade of A patency was observed in 100% of the first LIMA-target coronaries sites and 97.3% of the second sites. In the DLAD subgroup, FitzGibbon grade of A patency was observed in 99.1% of the first LIMA-target coronaries sites and 98.2% of the second sites. No significant difference was found in the LIMA graft patency rate between the two subgroups.
Discussion
The main finding of this study was sequential LIMA grafting received non-inferior mid-term LIMA graft patency rate to separate LIMA grafting, without evidence of worse in-hospital and follow-up clinical outcomes. This study reported 99.5% mid-term patency rate of the first LIMA-target coronaries sites and 97.7% of the second Sequential group, patients receiving sequential grafting of in situ skeletonized LIMA to the left coronary system with other conduits grafting; Control group, patients receiving separate grafting of in situ skeletonized LIMA to the LAD with other conduits grafting. sites after sequential grafting of in situ skeletonized LIMA to the left coronary system, which were similar to 98.2% mid-term patency rate after separate grafting of in situ skeletonized LIMA to the LAD. Trunk flow of sequential LIMA grafting was higher than that of separate LIMA grafting, which may contribute to stating the fact that graft patency rate of sequential LIMA grafting was not inferior to separate LIMA grafting. 16, 17) So, this study supported the strategy of sequential LIMA grafting. Previously, Wendt and colleagues 5) reported 100% patency rate of the diagonal anastomosis and 100% patency rate of the LAD anastomosis after sequential LIMA grafting at 5-year follow-up. The evidence came from Wendt's study was in line with the outcomes of the current study. However, a small sample size in Wendt's study (only 29 patients receiving sequential LIMA grafting) may result in weak results. Another previous study 4) reviewed 57 patients who received sequential LIMA grafting and concluded that revascularization of the LAD artery area using a single skeletonized LIMA resulted in excellent clinical outcomes and graft patency using sequential grafting. This evidence was consistent with the outcomes of the current study.
Another important finding was that two sequential LIMA graft configurations received similar mid-term LIMA graft patency rate and similar incidences of inhospital and follow-up adverse events. This study investigated and compared in-hospital and follow-up clinical outcomes and mid-term LIMA graft patency rate between the DOM subgroup and the DLAD subgroup and found that the strategy of sequential grafting of LIMA-D-OM, a rarely reported surgical strategy, was not inferior to the strategy of sequential grafting of LIMA-D-LAD, a common practice in some medical centers. Furthermore, the strategy of sequential grafting of LIMA-D-OM in combination with separate grafting of in situ skeletonized right internal mammary artery to the LAD was applied in our medical center. Then, complete left-sided internal mammary artery grafting was readily achieved, and the principle of multiple-origin blood supply was maintained, which may benefit patients with coronary artery disease.
It was noteworthy that although the trunk flow of sequential LIMA grafting was greater than that of separate LIMA grafting, flow of sequential LIMA segment between the two sequential anastomoses was lower than that of separate grafting of LIMA-LAD, which meant that the blood flow through LIMA graft to the LAD may be decreased in the case of sequential grafting of LIMA-D-LAD. However, the flow of sequential LIMA segments between the two sequential anastomoses was greater than 15 mL/minute for each patient (an average flow of 31 mL/minute) who received sequential LIMA grafting, exceeding the accepted lower threshold value. 16 ) And sequential grafting of LIMA to the left coronary system resulted in excellent clinical outcomes and mid-term LIMA graft patency rate for the second site (LAD or OM), which demonstrated that the "adverse effect of sequential LIMA grafting (i.e., reduction of blood flow through sequential LIMA graft to the LAD or the OM)" did not translate into more adverse events and inferior LIMA graft patency rate. It remained to be confirmed by long-term outcomes. In addition, patients in the sequential group were younger than those in the control group. The reason for this difference may be related to "young patients were more likely to requiring maximum utilization of LIMA." And patients in the DOM subgroup were younger than those in the DLAD subgroup, suggesting that bilateral internal mammary artery grafting was more often applied to young patients.
The strategy of sequential grafting of in situ skeletonized LIMA to the left coronary system may be a relatively favorable choice when planning bilateral IMA grafting or when there was a lack of available conduits. Surgeons were at liberty to choose sequential or separate in situ skeletonized LIMA grafting for each case. Factors influencing surgeons' preference may have included the length of available LIMA conduits (the distal LIMA bifurcation can loosely reach the second anastomosis); size of available LIMA conduits (the inner diameter of more than 2 mm); desire to increased manipulation of the LIMA conduits. And the geometric relationship between the two target coronary arteries should be considered when planning sequential LIMA grafting. 18) If the angle between the two target arteries was acute (< 60°), LIMA sequential anastomosis was feasible. However, if the lateral distance between the two anastomoses was greater than 4 cm, or the angle between the two target coronary arteries was greater than 60°, sequential anastomosis is generally avoided owing to a tendency for graft kinking. In addition, patients who had an anticipated life expectancy of less than a decade or patients with excessive obesity, advanced age with serious chronic obstructive pulmonary disease, and previous chest radiotherapy may not be suitable candidates for sequential LIMA grafting. Also, hemodialysis patients with arteriovenous shunt in their left arm may not be suitable candidates due to the potential for SEQUENTIAL LIMA GRAFTING vascular steal from the LIMA into the juxtaposed upper extremity arteriovenous fistula. 19) This study had some potential limitations. First, it was a single-center study. The unobserved confounds and selection biases between the two groups and between the two subgroups cannot be eliminated. Second, noninvasive coronary CT angiography was used to determine the IMA graft patency. Noninvasive coronary CT angiography may be less accurate for assessing the IMA graft patency than invasive coronary angiography, but it was more easily accepted by patients who schedule for an examination of graft patency. In recent decades, noninvasive imaging techniques have allowed direct visualization of atherosclerotic disease into coronary arteries and arterial and venous grafts and have shown an excellent correlation with invasive angiography. 20, 21) Finally, the duration of follow-up in this study was relatively short, and long-term outcomes need longer observation to confirm this result
Conclusions
This single-center retrospective study showed that sequential grafting of in situ skeletonized LIMA to the left coronary system resulted in excellent clinical outcomes and graft patency, and the two sequential LIMA graft configurations received similar clinical outcomes and graft patency.
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